The significance of changes in QLQ-C30 scores can be interpreted in terms of small, moderate, or large changes in quality of life as reported by patients in the SSQ. The magnitude of these changes also can be used to calculate the sample sizes required to detect a specified change in clinical trials.
No takes yet. Share an insight, caveat, or question.
Osoba et al. (1998) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: